Ecopetrol SA vs Health Care Select Sector SPDR Fund — how do they compare? Ecopetrol SA trades at $16.94 (market cap $33.11B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is the larger of the two by market cap, and Ecopetrol SA pays a 3.83% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecopetrol SA for 84 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| EC | XLV | |
|---|---|---|
Market Cap | $33.11B | $43.48B |
Volume | 993,598 | 11,121,431 |
Sector | Energy | — |
52-Week High | $18.26 | $175.68 |
52-Week Low | $8.61 | $141.95 |
Typical Hold Time | 84 Days | 100 Days |
Enterprise Value | $61.36B | — |
Dividend Yield | 3.83% | — |
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $16.94, up 1.86% with bearish technical signals despite recent management changes. The stock shows attractive valuation metrics with P/E of 7.97 and EV/EBITDA of 4, but faces declining revenue from $159.6B in 2022 to $119.7B in 2025. Recent earnings misses and negative cash flow trends offset the company's strong 17.67% ROE and 11.37% net margin.
While valuation appears compelling, EC faces significant headwinds including revenue decline, management turnover, and negative cash flow. Analyst consensus suggests caution with 54.55% hold ratings and $16.85 price target near current levels. Political influence and operational challenges present ongoing risks for investors.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →